It's never been explicitly stated by the company, other than it won't be on a patient by patient basis.
I'd still have expected confirmation that the first patient was dosed in combination without issue... given the entirety of our clinical program is contingent on this.
It's never been explicitly stated by the company, other than it...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
-0.015(1.30%) |
Mkt cap ! $197.1M | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.16 | $1.13 | $170.4K | 148.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5868 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 2062 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |